Merck & Co.: HSBC Raises Target Price To $150 From $135
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.